Announcement The HUTCHMED (China) Limited, a leading commercial-level, innovative biopharmaceutical company, declared its results from the FRUSICA-2 registration clinical trial of the sintilimab and fruquintinib merger for the advanced or metastatic renal cell carcinoma patients. The result...
Image Credit: Salesforce Announcement Salesforce is extending its Agentforce platform to restructure the enterprises' management in cybersecurity, IT service, customer experience, and compliance, merging artificial intelligence and automation to streamline the operations and alleviate the ...
Image Credit: Nature AI approach Over the last 30 years, the clinical trial setting has undergone a technological leap of faith, driving transformation, a transformation such as switching from manual data entry to electronic data capture. Most of the companies found it difficult to make others u...
Image Credit: ViiV Healthcare Announcement The ViiV Healthcare, a leading worldwide HIV specialist company owned by GSK, along with Shionogi and Pfizer as the shareholders, showcased a clinical presentation of over 60 abstracts, involving data from its industry-popular long-standing HIV tr...
Image Credit: Abingdon Health Announcement The UK’s medicines and healthcare products regulatory agency (MHRA) has introduced new plans to strengthen its partnership with the US Food and Drug Administration (FDA) to improve patients’ access and fruition to the patients for innovative...
Image Credit: Investors | Endo Announcement Endo, a full-fledged subsidiary of Mallinckrodt plc, showcased a total of nine presentations based on XIAFLEX (collagenase clostridium histolyticum, injection 0.9 mg) and Peyronie’s disease or PD. The presentation will be projected during t...
Image Credit: ET Pharma Announcement Novo Nordisk will acquire Akero Therapeutics for $5.2 billion, marking Novo as the latest major pharmaceutical company to enter a rapidly growing area in liver disease that has seen numerous high-profile deals emerge so far. With this acquisition, Novo ...
Image Credit: Forebes Announcement The UST, a leading technology and AI-dedicated solutions company, has cracked a deal with three significant healthcare companies worth USD 2 billion. With this, UST will strengthen its position as a valued, trustworthy partner to a few of the region's adv...
Image Credit: Suki AI Announcement Suki, the popular face of artificial intelligence (AI) for healthcare, has made new efforts targeted at the administrative hassles faced by nurses globally. This involves the introduction of an inaugural nursing association with the popular health systems...
Image Credit: Yahoo Finance Announcement Apogee Therapeutics Inc., a leading clinical-level biotechnology company accelerating optimization, novel biologics with standing ability for excellent profiles in the immunology and inflammatory (I and I) sector, has declared an underwritte...
